Reuters Market Eye - Novartis India Ltd
The sale of shares in Novartis India is intended to comply with the regulation that at least 25 percent of private companies shares' must be held by public shareholders by June.
Novartis India would need to sell a 1.42 percent stake to comply with those norms.
Novartis India shares gain 2.5 percent after earlier falling to their lowest level since May 17, 2010.
India's Supreme Court is due to decide on April 1 whether Novartis AG's cancer treatment Glivec deserves a patent in the country.
(Reporting by Manoj Dharra)